Journal Papers, Abstracts, and
Commentaries
| |
Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology,
and outcome.
Puoti M, Torti C, Ripamonti D, et al
J Acquir Immune Defic Syndr 2003 Mar 1;32(3):259-67
Abstract
|
Looking beyond highly active antiretroviral therapy:
drug-related
hepatotoxicity in patients
with human immunodeficiency virus infection.
Orenstein R, Tsogas N.
Pharmacotherapy 2002 Nov;22(11):1468-78
Abstract
|
Incidence of and risk factors for severe hepatotoxicity associated with
antiretroviral
combination therapy.
Wit FW, Weverling GJ, Weel J, et al
J Infect Dis 2002 Jul
1;186(1):23-31
Abstract
|
Hepatotoxicity associated with antiretroviral therapy containing dual
versus single protease
inhibitors in individuals coinfected with hepatitis C
virus and human immunodeficiency virus.
Cooper CL, Parbhakar MA, Angel JB.
Clin Infect Dis 2002 May
1;34(9):1259-63
Abstract
|
Acute liver failure associated with antiretroviral
treatment for HIV: a report of six
cases.
Clark SJ, Creighton S, Portmann
B, et al.
J Hepatol
2002
Feb;36(2):295-301
Abstract
|
Role of long-term nucleoside-analogue therapy in
lipodystrophy and metabolic
disorders
in human immunodeficiency virus-infected
patients.
Chene G, Angelini E, Cotte L, et al.
Clin Infect Dis
2002 Mar 1;34(5):649-57
Abstract
|
Rate and risk factors of liver toxicity in patients receiving antiretroviral
therapy
Lana R, Nunez M, Mendoza JL, Soriano V.
Med Clin (Barc) 2001 Nov 17;117(16):607-10
Abstract
|
|
|
|
General
ARV Events
Hepatic
Main Page